Genpact (G) drew fresh investor interest after launching its AI driven Deductions Recovery solution, an accounts receivable platform on Microsoft Azure that targets revenue leakage and unresolved claims for consumer goods companies.
See our latest analysis for Genpact.
While Genpact’s new AI driven Deductions Recovery platform has lifted sentiment and coincided with a 1 day share price return of 2.97%, the stock’s momentum has been weak overall, with the 30 day share price return down 10.79% and the 1 year total shareholder return down 35.46%.
If Genpact’s AI push has caught your attention and you want to see what other automation focused businesses are doing, take a look at 29 robotics and automation stocks.
After Genpact’s sharp share price reset, solid profitability and a compressed valuation are back in focus, especially with new AI products drawing attention. Is Genpact quietly undervalued at this level, or is the market already fully reflecting its next chapter of growth?
Most Popular Narrative: 31.5% Undervalued
Against a last close of $29.10, the most followed Genpact narrative anchors on a fair value of $42.45, built using a 7.95% discount rate.
Analysts expect earnings to reach $745.1 million (and earnings per share of $4.31) by about June 2029, up from $569.6 million today. The analysts are largely in agreement about this estimate.
Curious what earnings path, margin profile, and future P/E multiple line up with that fair value? The narrative leans on a detailed earnings ramp and changing share count assumptions that shape the long term payoff.
Result: Fair Value of $42.45 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this Genpact narrative still faces pressure from slowing legacy BPO demand and the risk that large, multi year, AI centric deals take longer to convert.
Find out about the key risks to this Genpact narrative.
Next Steps
If this Genpact story seems optimistic but uncertain, consider promptly reviewing the underlying data and forming your own view based on 4 key rewards.
Looking for more Genpact style investment ideas?
Do not stop with Genpact. Use the Simply Wall St Screener to identify other stocks that fit clear, disciplined criteria.
- Focus on income by reviewing companies that meet your yield preferences and financial strength standards through the 7 dividend fortresses.
- Look for value by scanning companies that combine solid fundamentals with attractive pricing using the 44 high quality undervalued stocks.
- Emphasize risk management by filtering for companies flagged as 74 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com